Cargando…
Targeted Therapy: A New Approach for the Treatment of Locally Advanced Oropharyngeal Cancer
Presented herein is a clinical study comprising 48 patients (42 men and 6 women) of working age (40–70 years), all of whom are suffering from locally advanced oropharyngeal cancer. A modern approach is applied to treat these patients,i.e., neoadjuvant targeted therapy, taking into account the biolog...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372996/ https://www.ncbi.nlm.nih.gov/pubmed/22708067 |
_version_ | 1782235394465595392 |
---|---|
author | Velsher, L.Z. Kosmynin, A.A. Byakhov, M.Yu. Duditskaya, T.K. Reshetov, D.N. |
author_facet | Velsher, L.Z. Kosmynin, A.A. Byakhov, M.Yu. Duditskaya, T.K. Reshetov, D.N. |
author_sort | Velsher, L.Z. |
collection | PubMed |
description | Presented herein is a clinical study comprising 48 patients (42 men and 6 women) of working age (40–70 years), all of whom are suffering from locally advanced oropharyngeal cancer. A modern approach is applied to treat these patients,i.e., neoadjuvant targeted therapy, taking into account the biological profile of the tumor. The use of gefitinib causes an antitumor effect in 90.5% of cases as opposed to 56.5% when no drug is applied. |
format | Online Article Text |
id | pubmed-3372996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | A.I. Gordeyev |
record_format | MEDLINE/PubMed |
spelling | pubmed-33729962012-06-15 Targeted Therapy: A New Approach for the Treatment of Locally Advanced Oropharyngeal Cancer Velsher, L.Z. Kosmynin, A.A. Byakhov, M.Yu. Duditskaya, T.K. Reshetov, D.N. Acta Naturae Research Article Presented herein is a clinical study comprising 48 patients (42 men and 6 women) of working age (40–70 years), all of whom are suffering from locally advanced oropharyngeal cancer. A modern approach is applied to treat these patients,i.e., neoadjuvant targeted therapy, taking into account the biological profile of the tumor. The use of gefitinib causes an antitumor effect in 90.5% of cases as opposed to 56.5% when no drug is applied. A.I. Gordeyev 2012 /pmc/articles/PMC3372996/ /pubmed/22708067 Text en Copyright © 2012 Park-media Ltd. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Velsher, L.Z. Kosmynin, A.A. Byakhov, M.Yu. Duditskaya, T.K. Reshetov, D.N. Targeted Therapy: A New Approach for the Treatment of Locally Advanced Oropharyngeal Cancer |
title | Targeted Therapy: A New Approach for the Treatment of Locally
Advanced Oropharyngeal Cancer |
title_full | Targeted Therapy: A New Approach for the Treatment of Locally
Advanced Oropharyngeal Cancer |
title_fullStr | Targeted Therapy: A New Approach for the Treatment of Locally
Advanced Oropharyngeal Cancer |
title_full_unstemmed | Targeted Therapy: A New Approach for the Treatment of Locally
Advanced Oropharyngeal Cancer |
title_short | Targeted Therapy: A New Approach for the Treatment of Locally
Advanced Oropharyngeal Cancer |
title_sort | targeted therapy: a new approach for the treatment of locally
advanced oropharyngeal cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372996/ https://www.ncbi.nlm.nih.gov/pubmed/22708067 |
work_keys_str_mv | AT velsherlz targetedtherapyanewapproachforthetreatmentoflocallyadvancedoropharyngealcancer AT kosmyninaa targetedtherapyanewapproachforthetreatmentoflocallyadvancedoropharyngealcancer AT byakhovmyu targetedtherapyanewapproachforthetreatmentoflocallyadvancedoropharyngealcancer AT duditskayatk targetedtherapyanewapproachforthetreatmentoflocallyadvancedoropharyngealcancer AT reshetovdn targetedtherapyanewapproachforthetreatmentoflocallyadvancedoropharyngealcancer |